Abstract:Objective To evaluate the clinical value of contrast enhanced ultrasound(CEUS) for patients with hepatocellular carcinoma in identifying the ablation range and designing the treatment protocol before radiofrequency ablation(RFA) treatment and to compare the efficacy of RFA after CEUS with the efficacy of RFA after fundamental ultrasonography(US) without contrast.Methods One hundred sixty-one patients with hepatocellular carcinoma(HCC) were suitable for percutaneous RFA and underwent US-guided RFA treatment.CEUS was performed for 77 patients pre-treatment(CEUS group) and fundamental US without contrast enhancement was performed for the remaining 84 patients pre-treatment(non-CEUS group).There were no significant differences in clinical data between the two groups;the average diameters of the lesions in CEUS group and non-CEUS group were(3.6±1.2) cm and(3.5±1.1) cm,respectively.Regular follow-up after treatment was performed using fundamental US and contrast-enhanced computed tomography(CECT) or CEUS(or both).No residue or local recurrence on CECT at least 6 months after treatment was classified as complete ablation.Results In the CEUS group,77 cases with 105 lesions were treated with RFA.There were 59 lesions(56.2%) that were larger during the arterial phase and 49 lesions(46.7%) that had a more irregular shape during the arterial phase than in fundamental US.Feeding vessels were detected with CEUS in 37 of 52 lesions larger than 3.5 cm(71.1%).CEUS showed 16 small lesions(≤2.0 cm) in 10 cases,5 of which had 5 hepatic distant recurrences after RFA which coexisted with liver cirrhosis.Another 5 cases had 11 satellite lesions around the main tumor.The average number of RFA sessions in the CEUS group and non-CEUS group were 1.2 and 1.5 respectively.During the 6 to 36 months of follow-up,the complete ablation rate in the CEUS group was significantly higher than that in the non-CEUS group(95.4% vs 87.8%,P=0.042).The average survival time in the CEUS group was longer than that of non-CEUS group [(34.2±1.2) months vs(30.2±1.6) months,P=0.028].Conclusions CEUS is used to accurately identify the tumor invasive range and sensitively detect minute or satellite lesions and the feeding vessel of the tumor.CEUS provides important information and evidence for planning the RFA protocol and may improve the efficacy of RFA treatment of liver tumors.

Evaluation of coagulated area after microwave ablation of liver carcinomas by gray-scale ultrasound

Clinical Assessment of Sonographically Guided Microwave Coagulation Therapy in Patients with Liver Carcinoma

Application of Contrast Enhanced Ultrasonography in Microwave Ablation for Liver Cancer

Application of CELLS in the Selection of Indications of Hepatic Malignancies Treated with Microwave Ablation

Contrast-enhanced ultrasonography in the characterization of focal liver lesions before microwave ablation therapy

Comparison of Real-Time Contrast-Enhanced Ultrasonography and Standard Ultrasonography in Liver Cancer Microwave Ablation

Ultrasonographic evaluation of coagulative necrotic area in patients with hepatocellular carcinoma during percutaneous sonographically guided microwave coagulation therapy

Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.

Experimental study of assessing the size of microwave coagulative area with dynamic grey-scale contrast enhanced ultrasonography

Ultrasound guided percutaneous microwave coagulation therapy for liver carcinoma:32 cases clinical analysis

CEUS-Based Radiomics Can Show Changes in Protein Levels in Liver Metastases after Incomplete Thermal Ablation.

Clinical value of contrast enhanced ultrasound for identifying ablation range and designing treatment protocol of radiofrequency ablation in hepatocellular carcinoma

[Results of Enhanced Ultrasonography in Assessing Hepatoma Treated with Radiofrequency Ablation].

Application of contrast-enhanced ultrasound and enhanced CT in diagnosis of liver cancer and evaluation of radiofrequency ablation

Contrast-enhanced Ultrasound in the Assessment of Efficacy of Radiofrequency Ablation for Hepatocellular Carcinoma

The clinical application of contrast enhanced ultrasonography in radiofrequency ablation therapy for residual and recurrent hepatic neoplasms

Application study of using ultrasonic integral backscatter to monitor microwave coagulation therapy

Clinical Analysis of Ultrasound-guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma

Shear Wave Elastography in Evaluating the Efficacy of Liver Microwave Ablation: An Experimental Study

Radiofrequency ablation of small hepatic malignancies guided by contrast enhanced ultrasonography

Study on microwave ablation temperature prediction model based on grayscale ultrasound texture and machine learning